"Haloperidol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
Below are MeSH descriptors whose meaning is more general than "Haloperidol".
Below are MeSH descriptors whose meaning is more specific than "Haloperidol".
This graph shows the total number of publications written about "Haloperidol" by people in Harvard Catalyst Profiles by year, and whether "Haloperidol" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 4 | 7 | 11 |
| 1995 | 5 | 4 | 9 |
| 1996 | 5 | 4 | 9 |
| 1997 | 4 | 7 | 11 |
| 1998 | 1 | 4 | 5 |
| 1999 | 4 | 5 | 9 |
| 2000 | 2 | 4 | 6 |
| 2001 | 4 | 5 | 9 |
| 2002 | 6 | 3 | 9 |
| 2003 | 5 | 4 | 9 |
| 2004 | 4 | 4 | 8 |
| 2005 | 4 | 9 | 13 |
| 2006 | 4 | 7 | 11 |
| 2007 | 4 | 4 | 8 |
| 2008 | 6 | 5 | 11 |
| 2009 | 1 | 4 | 5 |
| 2010 | 2 | 4 | 6 |
| 2011 | 2 | 4 | 6 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 4 | 7 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 4 | 6 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 4 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 1 | 3 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 7 | 7 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Haloperidol" by people in Profiles.
-
How does haloperidol influence the long-term outcomes of delirium? Intensive Care Med. 2024 Feb; 50(2):269-271.
-
Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial. Crit Care. 2023 10 30; 27(1):413.
-
Second International Consensus Study of Antipsychotic Dosing (ICSAD-2). J Psychopharmacol. 2023 10; 37(10):982-991.
-
Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses. Psychol Med. 2023 Dec; 53(16):7677-7684.
-
Research letter: Clonidine is associated with faster first resolution of incident ICU delirium than antipsychotics. J Crit Care. 2024 02; 79:154433.
-
Trends in use of antipsychotics and psychoactive drugs in older patients after major surgery. J Am Geriatr Soc. 2023 12; 71(12):3755-3767.
-
Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study. Ann Intern Med. 2023 09; 176(9):1153-1162.
-
Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization. JAMA Netw Open. 2023 02 01; 6(2):e230063.
-
Pharmacologic treatment of delirium symptoms: A systematic review. Gen Hosp Psychiatry. 2022 Nov-Dec; 79:60-75.
-
Intravenous Haloperidol Has a Limited Role in the Modern Emergency Department. Ann Emerg Med. 2023 01; 81(1):96-98.